Masatoshi Kudo, MD, PhD | Authors


Potential for Systemic Therapy in the Adjuvant Setting of HCC

October 03, 2018

Masatoshi Kudo, MD, PhD, discusses the potential for systemic therapy in the adjuvant setting of hepatocellular carcinoma. While current trials are investigating this therapy in advanced stage HCC, Kudo believes it could benefit patients following a surgery resecting an aberration.